Header Logo

Connection

Theo Manschreck to Psychotic Disorders

This is a "connection" page, showing publications Theo Manschreck has written about Psychotic Disorders.
Connection Strength

1.697
  1. Shahzade C, Chun J, DeLisi LE, Manschreck TC. Patterns in adolescent cannabis use predict the onset and symptom structure of schizophrenia-spectrum disorder. Schizophr Res. 2018 07; 197:539-543.
    View in: PubMed
    Score: 0.649
  2. Manschreck TC, Maher BA, Beaudette SM, Redmond DA. Context memory in schizoaffective and schizophrenic disorders. Schizophr Res. 1997 Aug 29; 26(2-3):153-61.
    View in: PubMed
    Score: 0.155
  3. Pillai A, Schooler NR, Peter D, Looney SW, Goff DC, Kopelowicz A, Lauriello J, Manschreck T, Mendelowitz A, Miller DD, Severe JB, Wilson DR, Ames D, Bustillo J, Kane JM, Buckley PF. Predicting relapse in schizophrenia: Is BDNF a plausible biological marker? Schizophr Res. 2018 03; 193:263-268.
    View in: PubMed
    Score: 0.153
  4. Buckley PF, Schooler NR, Goff DC, Kopelowicz A, Lauriello J, Manschreck TC, Mendelowitz A, Miller DD, Wilson DR, Ames D, Bustillo JR, Kane JM, Looney SW. Comparison of Injectable and Oral Antipsychotics in Relapse Rates in a Pragmatic 30-Month Schizophrenia Relapse Prevention Study. Psychiatr Serv. 2016 12 01; 67(12):1370-1372.
    View in: PubMed
    Score: 0.144
  5. Manschreck TC, Redmond DA, Beaudette SM. Clozapine in the back wards. Ann Clin Psychiatry. 1994 Dec; 6(4):215-25.
    View in: PubMed
    Score: 0.128
  6. Buckley PF, Schooler NR, Goff DC, Hsiao J, Kopelowicz A, Lauriello J, Manschreck T, Mendelowitz AJ, Miller del D, Severe JB, Wilson DR, Ames D, Bustillo J, Mintz J, Kane JM. Comparison of SGA oral medications and a long-acting injectable SGA: the PROACTIVE study. Schizophr Bull. 2015 Mar; 41(2):449-59.
    View in: PubMed
    Score: 0.123
  7. Chun J, Karam ZN, Marzinzik F, Kamali M, O'Donnell L, Tso IF, Manschreck TC, McInnis M, Deldin PJ. Can P300 distinguish among schizophrenia, schizoaffective and bipolar I disorders? An ERP study of response inhibition. Schizophr Res. 2013 Dec; 151(1-3):175-84.
    View in: PubMed
    Score: 0.119
  8. Galvez-Buccollini JA, Proal AC, Tomaselli V, Trachtenberg M, Coconcea C, Chun J, Manschreck T, Fleming J, Delisi LE. Association between age at onset of psychosis and age at onset of cannabis use in non-affective psychosis. Schizophr Res. 2012 Aug; 139(1-3):157-60.
    View in: PubMed
    Score: 0.108
  9. Manschreck TC, Khan NL. Recent advances in the treatment of delusional disorder. Can J Psychiatry. 2006 Feb; 51(2):114-9.
    View in: PubMed
    Score: 0.069
  10. Manschreck TC, Petri M. The atypical psychoses. Cult Med Psychiatry. 1978 Sep; 2(3):233-68.
    View in: PubMed
    Score: 0.041
  11. Jacobson G, Baldessarini RJ, Manschreck T. Tardive and withdrawal dyskinesia associated with haloperidol. Am J Psychiatry. 1974 Aug; 131(8):910-3.
    View in: PubMed
    Score: 0.008
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.